Clinical Trial Update: Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of CG200745 PPA for myelodysplastic syndrome is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• CG200745 PPA (CG200745 PPA)

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: UNKNOWN